Sökning: onr:"swepub:oai:DiVA.org:uu-502265" > Development of sens...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04614naa a2200565 4500 | |
001 | oai:DiVA.org:uu-502265 | |
003 | SwePub | |
008 | 230524s2023 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:151178933 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-5022652 URI |
024 | 7 | a https://doi.org/10.1111/all.155682 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1511789332 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Tedner, Sandra G.u Karolinska Institutet4 aut |
245 | 1 0 | a Development of sensitization to peanut and storage proteins and relation to markers of airway and systemic inflammation :b A 24-year follow-up |
264 | c 2022-11-14 | |
264 | 1 | b John Wiley & Sons,c 2023 |
338 | a electronic2 rdacarrier | |
520 | a BackgroundLong-time data of peanut allergy over time is sparse. We aimed to study the longitudinal development of sensitization to peanut extract and storage protein allergen molecules and associations with asthma status, airway and systemic inflammation markers.MethodsThe Swedish birth cohort BAMSE followed 4089 participants with questionnaires, clinical investigations and blood sampling between 0 and 24 years. Information on (i) background factors at 2 months, (ii) peanut allergy symptoms and IgE data (ImmunoCAP) at 4, 8, 16, and 24 years, and (iii) IgE to storage proteins, lung function data including exhaled nitric oxide (FENO) as well as systemic inflammatory markers at 24 years of age were collected.ResultsThe prevalence of peanut extract sensitization, defined as IgE ≥ 0.35 kUA/L, was 5.4%, 8.0%, 7.5%, and 6.2% at 4, 8, 16, and 24 years of age, respectively. Between 8 and 24 years of age, (33/1565) participants developed IgE-ab to peanut extract (median 1,4, range 0.7–2.6 kUA/L), and among those 85% were also sensitized to birch. Only six individuals developed sensitization to Ara h 2 (≥0.1 kUA/L) between 8 and 24 years of age, of whom three had an IgE-ab level between 0.1–0.12 kUA/L. Storage protein sensitization was associated with elevated FENO, blood eosinophils and type 2 inflammation-related systemic proteins.ConclusionSensitization to peanut extract after 4 years of age is mainly induced by birch cross-sensitization and IgE to Ara h 2 rarely emerges after eight years of age. Storage protein sensitization is associated with respiratory and systemic inflammation. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Lungmedicin och allergi0 (SwePub)302192 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Respiratory Medicine and Allergy0 (SwePub)302192 hsv//eng |
653 | a birth cohort | |
653 | a FENO | |
653 | a molecular allergology | |
653 | a OLINK | |
653 | a peanut allergy | |
653 | a sensitization | |
700 | 1 | a Klevebro, Susannau Karolinska Institutet4 aut |
700 | 1 | a Bergström, Annau Karolinska Institutet4 aut |
700 | 1 | a Kull, Ingeru Karolinska Institutet4 aut |
700 | 1 | a Andersson, Niklasu Karolinska Institutet4 aut |
700 | 1 | a Borres, Magnus P.,d 1956-u Uppsala universitet,Pediatrisk inflammations- och metabolismforskning samt barnhälsa,Thermo Fisher Scientific, Uppsala, Sweden4 aut0 (Swepub:uu)magbo385 |
700 | 1 | a Ballardini, Nataliau Karolinska Institutet4 aut |
700 | 1 | a Westman, Maritu Karolinska Inst, Div Immunol & Allergy, Dept Med Solna, Stockholm, Sweden.;Univ Hosp, Stockholm, Sweden.;Praktikertjanst, St Goran Asthma & Allergy Clin, Stockholm, Sweden.4 aut |
700 | 1 | a Konradsen, Jon R.u Karolinska Institutet4 aut |
700 | 1 | a van Hage, Marianneu Karolinska Institutet4 aut |
700 | 1 | a Nilsson, Carolineu Karolinska Institutet4 aut |
700 | 1 | a Melén, Eriku Karolinska Institutet4 aut |
700 | 1 | a Asarnoj, Annau Karolinska Institutet4 aut |
710 | 2 | a Karolinska Institutetb Pediatrisk inflammations- och metabolismforskning samt barnhälsa4 org |
773 | 0 | t Allergy. European Journal of Allergy and Clinical Immunologyd : John Wiley & Sonsg 78:2, s. 488-499q 78:2<488-499x 0105-4538x 1398-9995 |
856 | 4 | u https://doi.org/10.1111/all.15568y Fulltext |
856 | 4 | u https://uu.diva-portal.org/smash/get/diva2:1759078/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-502265 |
856 | 4 8 | u https://doi.org/10.1111/all.15568 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:151178933 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.